Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction

Toxicology Letters

Volumn 195, Issue 2-3, 2010, Pages 119-126

  Li, Qun ^a   Turdi, Subat ^a   Thomas, D Paul ^a   Zhou, Tianjie ^b   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b Laramie High School   (United States)

Author keywords

Angiogenesis; Apoptosis; Contraction; Intracellular Ca2+ transients; Mesenchymal stem cell; Myocardial infarction

Indexed keywords

CALCIUM ION; ENHANCED GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL HETEROGENEITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; FLUORESCENCE MICROSCOPY; HEART CONTRACTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; STAINING; TISSUE ENGINEERING;

ANIMALS; CALCIUM; INJECTIONS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

MUS;

EID: 77952543737     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.03.009     Document Type: Article

References (31)

1. Anjos-Afonso F., Siapati E.K., Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 2004, 117:5655-5664.
2. Berry M.F., Engler A.J., Woo Y.J., Pirolli T.J., Bish L.T., Jayasankar V., Morine K.J., Gardner T.J., Discher D.E., Sweeney H.L. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H2196-H2203.
3. Doser T.A., Turdi S., Thomas D.P., Epstein P.N., Li S.Y., Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009, 119:1941-1949.
4. Du Y.Y., Zhou S.H., Zhou T., Su H., Pan H.W., Du W.H., Liu B., Liu Q.M. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy 2008, 10:469-478.
5. Fukuhara S., Tomita S., Nakatani T., Yutani C., Kitamura S. Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. J. Heart Lung Transplant. 2005, 24:67-72.
6. Grauss R.W., Winter E.M., van T.J., Pijnappels D.A., Steijn R.V., Hogers B., van der Geest R.J., de Vries A.A., Steendijk P., van der L.A., Gittenberger-de Groot A.C., Schalij M.J., Atsma D.E. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2438-H2447.
7. Hakuno D., Fukuda K., Makino S., Konishi F., Tomita Y., Manabe T., Suzuki Y., Umezawa A., Ogawa S. Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 2002, 105:380-386.
8. Hida N., Nishiyama N., Miyoshi S., Kira S., Segawa K., Uyama T., Mori T., Miyado K., Ikegami Y., Cui C., Kiyono T., Kyo S., Shimizu T., Okano T., Sakamoto M., Ogawa S., Umezawa A. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008, 26:1695-1704.
9. Imanishi Y., Saito A., Komoda H., Kitagawa-Sakakida S., Miyagawa S., Kondoh H., Ichikawa H., Sawa Y. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J. Mol. Cell Cardiol. 2008, 44:662-671.
10. Iso Y., Spees J.L., Serrano C., Bakondi B., Pochampally R., Song Y.H., Sobel B.E., Delafontaine P., Prockop D.J. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun. 2007, 354:700-706.
11. Leor J., Gerecht S., Cohen S., Miller L., Holbova R., Ziskind A., Shachar M., Feinberg M.S., Guetta E., Itskovitz-Eldor J. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007, 93:1278-1284.
12. Li Q., Ren J. Cardiac overexpression of metallothionein rescues chronic alcohol intake-induced cardiomyocyte dysfunction: role of Akt, mammalian target of rapamycin and ribosomal p70s6 kinase. Alcohol 2006, 41:585-592.
13. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., Castaldo C., Cascapera S., Bohm M., Quaini F., Urbanek K., Leri A., Hintze T.H., Kajstura J., Anversa P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8966-8971.
14. Lu M.J., Zhao S.H., Liu S., Zhang P.H., Jiang S.L., Zhang Y., Yan C.W., Liu Q., Ling J., Huang L.J., He Z.X., Yang M.F., Hu S.S. Assessment of therapeutic effects of stem cell transplantation in heart failure patients with old myocardial infarction by magnetic resonance imaging. Zhonghua Xin. Xue. Guan. Bing. Za Zhi. 2008, 36:969-974.
15. Ma N., Stamm C., Kaminski A., Li W., Kleine H.D., Muller-Hilke B., Zhang L., Ladilov Y., Egger D., Steinhoff G. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 2005, 66:45-54.
16. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., McIntosh K.R., Mosca J.D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 2003, 10:228-241.
17. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999, 103:697-705.
18. Martin F.T., Dwyer R.M., Kelly J., Khan S., Murphy J.M., Curran C., Miller N., Hennessy E., Dockery P., Barry F.P., O'Brien T., Kerin M.J. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 2010, 10.1007/s10549-010-0734-1.
19. McCormick R.J., Musch T.I., Bergman B.C., Thomas D.P. Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am. J. Physiol. 1994, 266:H354-H359.
20. Nishiya D., Omura T., Shimada K., Matsumoto R., Kusuyama T., Enomoto S., Iwao H., Takeuchi K., Yoshikawa J., Yoshiyama M. Effects of erythropoietin on cardiac remodeling after myocardial infarction. J. Pharmacol. Sci. 2006, 101:31-39.
21. Piao H., Youn T.J., Kwon J.S., Kim Y.H., Bae J.W., Bora S., Kim D.W., Cho M.C., Lee M.M., Park Y.B. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur. J. Heart Fail. 2005, 7:730-738.
22. Ren J., Babcock S.A., Li Q., Huff A.F., Li S.Y., Doser T.A. Aldehyde dehydrogenase-2 transgene ameliorates chronic alcohol ingestion-induced apoptosis in cerebral cortex. Toxicol. Lett. 2009, 187:149-156.
23. Tang J., Xie Q., Pan G., Wang J., Wang M. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur. J. Cardiothorac. Surg. 2006, 30:353-361.
24. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
25. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T., Jia Z.Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999, 100:II247-II256.
26. Tomita Y., Makino S., Hakuno D., Hattan N., Kimura K., Miyoshi S., Murata M., Ieda M., Fukuda K. Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Med. Biol. Eng. Comput. 2007, 45:209-220.
27. Urbanek K., Torella D., Sheikh F., De A.A., Nurzynska D., Silvestri F., Beltrami C.A., Bussani R., Beltrami A.P., Quaini F., Bolli R., Leri A., Kajstura J., Anversa P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8692-8697.
28. Vertesaljai M., Piroth Z., Fontos G., Andreka G., Font G., Szantho G., Lueff S., Reti M., Masszi T., Ablonczy L., Juhasz E.D., Simor T., Turner M.S., Andreka P. Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy. Heart Fail. Rev. 2008, 13:227-244.
29. Wang Y.Q., Wang M., Zhang P., Song J.J., Li Y.P., Hou S.H., Huang C.X. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction. Chin. Med. J. (Engl.) 2008, 121:2290-2298.
30. Yang X., Doser T.A., Fang C.X., Nunn J.M., Janardhanan R., Zhu M., Sreejayan N., Quinn M.T., Ren J. Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress. FASEB J. 2006, 20:1024-1026.
31. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 2001, 33:907-921.